- Home
- AIP vs SCPH Comparison
AIP vs SCPH Comparison
Compare AIP & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIP
- SCPH
- Stock Information
- Founded
- AIP 2003
- SCPH 2013
- Country
- AIP United States
- SCPH United States
- Employees
- AIP N/A
- SCPH N/A
- Industry
- AIP Semiconductors
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AIP Technology
- SCPH Health Care
- Exchange
- AIP Nasdaq
- SCPH Nasdaq
- Market Cap
- AIP 277.9M
- SCPH 274.7M
- IPO Year
- AIP 2021
- SCPH 2017
- Fundamental
- Price
- AIP $7.80
- SCPH $3.46
- Analyst Decision
- AIP Strong Buy
- SCPH Strong Buy
- Analyst Count
- AIP 4
- SCPH 2
- Target Price
- AIP $13.00
- SCPH $15.00
- AVG Volume (30 Days)
- AIP 116.2K
- SCPH 470.9K
- Earning Date
- AIP 11-05-2024
- SCPH 11-13-2024
- Dividend Yield
- AIP N/A
- SCPH N/A
- EPS Growth
- AIP N/A
- SCPH N/A
- EPS
- AIP N/A
- SCPH N/A
- Revenue
- AIP $54,739,000.00
- SCPH $30,278,000.00
- Revenue This Year
- AIP $7.87
- SCPH $195.62
- Revenue Next Year
- AIP $19.23
- SCPH $145.07
- P/E Ratio
- AIP N/A
- SCPH N/A
- Revenue Growth
- AIP 4.53
- SCPH 303.87
- 52 Week Low
- AIP $4.53
- SCPH $3.08
- 52 Week High
- AIP $9.54
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- AIP 52.94
- SCPH 30.73
- Support Level
- AIP $7.97
- SCPH $4.00
- Resistance Level
- AIP $8.58
- SCPH $4.60
- Average True Range (ATR)
- AIP 0.44
- SCPH 0.23
- MACD
- AIP 0.07
- SCPH -0.07
- Stochastic Oscillator
- AIP 54.59
- SCPH 25.25
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.